Scientists Find Natural Brake That Slows Cancer Growth

Scientists in Spain have discovered a natural mechanism inside the body that acts like a brake pedal on cancer growth, potentially opening new doors for predicting which tumors might become aggressive.

The international research team, co-led by institutes in Cantabria and the Basque region, found that a protein called ASPA naturally helps stop healthy cells from becoming cancer's accomplices. Their findings appeared in Nature Communications earlier this month.

Here's what makes this exciting: tumors aren't just made of cancer cells. They're surrounded by normal cells like fibroblasts, which usually keep tissue healthy and structured. But cancer can hijack these innocent bystander cells, reprogramming them to help tumors grow and spread.

The researchers discovered that ASPA acts as a natural guardian, preventing this corruption from happening. When ASPA levels stay high, fibroblasts resist the tumor's influence. But as cancer progresses, ASPA levels drop, and those once-healthy cells start helping the tumor instead.

"During the past decade, we pursued a major question: how do tumors deploy adaptive mechanisms that sustain disease progression?" says Arkaitz Carracedo, one of the lead researchers. The answer led them to focus on the normal cells living inside tumors.

Using advanced cellular models and single-cell sequencing technology, the team tracked exactly how ASPA works. The protein blocks a molecular pathway called TGFβ signaling, which is responsible for turning normal fibroblasts into cancer-associated fibroblasts.

The Bright Side

The discovery means doctors might eventually use ASPA levels as a warning sign. When the protein is low, it could indicate a tumor is more likely to grow aggressively or spread to other parts of the body.

While this fundamental research won't lead to immediate treatments, it gives scientists a new target to explore. Future therapies might work by boosting ASPA levels or mimicking its protective effects, helping the body's own cells resist cancer's influence.

The work was possible because of patients who donated biological samples for research and support from multiple cancer research organizations across Europe. Two of the lead researchers, Carracedo and Fernando Calvo, received grants from the European Research Council to pursue this curiosity-driven science.

The study examined multiple cancer types, showing that ASPA's protective role isn't limited to just one kind of tumor. That broad relevance makes the discovery even more promising for future applications.

This research represents a shift in how scientists think about fighting cancer: not just attacking the cancer cells themselves, but understanding and protecting the healthy cells that tumors try to recruit as allies.